Cagrilintide: Research Peptide Overview

Cagrilintide, also cataloged as AM833, is a synthetic long-acting analogue of human amylin (islet amyloid polypeptide), handled in laboratories as a lyophilized powder. It carries CAS number 1415456-99-3 and a molecular formula of C194H312N54O59S2 with an average molecular weight of approximately 4409 g/mol.
What it is
Cagrilintide is a 32-residue amylin analogue modified with a lipid side chain, a structural strategy used in peptide chemistry to extend circulating half-life by promoting reversible albumin association. Amylin itself is a pancreatic islet peptide co-secreted with insulin, and analogues of it are studied in receptor-pharmacology literature for their interaction with the calcitonin receptor and receptor-activity-modifying protein (RAMP) complexes that together form the amylin receptor family. It is an investigational compound and is not approved by the FDA for any use.
Stability and storage in the literature
The lyophilized powder is best stored at -20 C in a sealed, desiccated container protected from light, conditions under which peptide powders are generally stable long-term. Once in solution, peptides are markedly less stable than in the dry state; laboratories typically aliquot to avoid repeated freeze-thaw cycles. Refer to the lot label for the expiration date.
Frequently asked questions
What is cagrilintide?
Cagrilintide (also cataloged as AM833) is a synthetic long-acting analogue of human amylin, a 32-residue peptide modified with a lipid side chain. It is, handled in laboratories as a lyophilized powder for laboratory research use only and is not a drug, food, or cosmetic.
What is the molecular formula and weight of cagrilintide?
The molecular formula is C194H312N54O59S2 with an average molecular weight of approximately 4409 g/mol (PubChem CID 171397054). Its CAS registry number is 1415456-99-3.
What receptor family does the amylin literature associate with cagrilintide?
Published receptor-pharmacology work on amylin analogues describes interaction with the amylin receptor family, formed by the calcitonin receptor in complex with receptor-activity-modifying proteins (RAMP1, RAMP2, RAMP3). This is a description of in-vitro receptor pharmacology, not a statement about outcomes in humans.
Is cagrilintide approved by the FDA?
No. Cagrilintide is an investigational compound.
How should cagrilintide be stored?
Store the lyophilized powder at -20 C, sealed, desiccated, and protected from light. Peptides in solution are considerably less stable than the dry powder, so aliquoting to avoid repeated freeze-thaw cycles is standard laboratory practice.
For laboratory research use only. Products sold by California Standard Peptides are not drugs, foods, supplements or cosmetics and are not for human or veterinary use. This article summarises published literature; it is not medical advice and not a usage guide.